PortnoyLaw_LogoHighResRoundLogoOnly.jpg
MacroGenics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2024 Deadline to file Lead Plaintiff Motion
23 sept. 2024 15h29 HE | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MacroGenics, Inc....
MacroGenics, Inc. Class Action Lawsuit
Lead Plaintiff Deadline Quickly Approaching in MacroGenics, Inc. (MGNX) Class Action – Shareholders Should Contact Robbins LLP for Information
11 sept. 2024 14h50 HE | Robbins LLP
Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
MacroGenics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2024 Deadline to file Lead Plaintiff Motion.
30 août 2024 15h20 HE | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MacroGenics, Inc....
MacroGenics, Inc.
Robbins LLP Reminds MacroGenics, Inc. (MGNXX) Investors of the Class Action Lawsuit and Pending Lead Plaintiff Deadline
20 août 2024 16h47 HE | Robbins LLP
Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
MacroGenics, Inc. Class Action Lawsuit
MacroGenics, Inc. Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against MGNX
07 août 2024 16h31 HE | Robbins LLP
Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
MacroGenics, Inc. Class Action Lawsuit
Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against MacroGenics, Inc. (MGNX)
30 juil. 2024 22h18 HE | Robbins LLP
Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
Block & Leviton LLP Logo
MacroGenics ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Encourages Investors to Contact the Firm to Learn More
29 juil. 2024 11h39 HE | Block & Leviton LLP
Block & Leviton announces that a securities fraud lawsuit has been filed against MacroGenics, Inc. (NASDAQ: MGNX) and certain of its executives.
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
MacroGenics, Inc. Investors: Company Investigated by the Portnoy Law Firm
24 juin 2024 15h13 HE | Portnoy Law
LOS ANGELES, June 24, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises MacroGenics, Inc....
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
MacroGenics, Inc. Investors: Company Investigated by the Portnoy Law Firm
17 juin 2021 14h49 HE | Portnoy Law
LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX) investors that the firm has initiated an investigation...